Integra Lifesciences Holdings Corp (IART)
28.73
-0.46
(-1.58%)
USD |
NASDAQ |
Jul 03, 16:00
Integra Lifesciences Holdings Research and Development Expense (Annual): 104.19M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 104.19M |
| December 31, 2022 | 101.19M |
| December 31, 2021 | 93.05M |
| December 31, 2020 | 77.38M |
| December 31, 2019 | 79.57M |
| December 31, 2018 | 78.04M |
| December 31, 2017 | 63.46M |
| December 31, 2016 | 58.16M |
| December 31, 2015 | 50.90M |
| December 31, 2014 | 43.56M |
| December 31, 2013 | 42.62M |
| December 31, 2012 | 51.01M |
| December 31, 2011 | 51.45M |
| December 31, 2010 | 48.11M |
| December 31, 2009 | 44.28M |
| Date | Value |
|---|---|
| December 31, 2008 | 60.50M |
| December 31, 2007 | 30.66M |
| December 31, 2006 | 25.73M |
| December 31, 2005 | 11.96M |
| December 31, 2004 | 14.12M |
| December 31, 2003 | 12.81M |
| December 31, 2002 | 8.304M |
| December 31, 2001 | 7.992M |
| December 31, 2000 | 7.524M |
| December 31, 1999 | 8.893M |
| December 31, 1998 | 8.424M |
| December 31, 1997 | 6.20M |
| December 31, 1996 | 6.30M |
| December 31, 1995 | 5.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
77.38M
Minimum
2020
104.19M
Maximum
2023
91.08M
Average
93.05M
Median
2021
Research and Development Expense (Annual) Benchmarks
| OraSure Technologies Inc | 33.73M |
| Boston Scientific Corp | 1.414B |
| Insulet Corp | 205.00M |
| ResMed Inc | 287.64M |
| Stryker Corp | 1.388B |